Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMT1 | P30419 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MC4R | P32245 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14412223 | 0.87 | NMT1 (0.52) | NMT1RAB9AHSD17B10KDM4ENPC1 | |
| SCHEMBL12759448 | 0.84 | TGFBR1 (0.48) | NMT1ALDH1A1MAPTRAB9ARIPK2 | |
| SCHEMBL17264894 | 0.82 | NMT1 (0.52) | NMT1RAB9AHSD17B10KDM4ENPC1 | |
| SCHEMBL31319322 | 0.80 | MC4R (0.41) | NMT1ALDH1A1MAPTRAB9ARECQL | |
| SCHEMBL12277262 | 0.80 | MC4R (0.44) | ALDH1A1MAPTMAPK1RAB9AMC4R | |
| SCHEMBL29711750 | 0.79 | HSD17B2 (0.48) | NMT1RIPK2NTRK1 | |
| SCHEMBL28469346 | 0.79 | NMT1 (0.44) | NMT1RAB9AHSD17B10KDM4ENPC1 | |
| SCHEMBL3488664 | 0.79 | IDO1 (0.49) | NMT1ALDH1A1MAPTRAB9AAPOBEC3G | |
| SCHEMBL12320076 | 0.79 | KDR (0.47) | NMT1ALDH1A1HSD17B10KDM4ERIPK2 | |
| SCHEMBL3970148 | 0.79 | MAP4K4 (0.46) | NMT1ALDH1A1MAPTRAB9ARECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105229009-B | 2-phenylimidazo [1,2-A ] pyrimidines as imaging agents | 豪夫迈·罗氏有限公司 | 2017-09-29 | — | — | CN | claimed |
| CN-105229009-A | 2-phenylimidazo [1,2-A ] pyrimidines as imaging agents | HOFFMANN LA ROCHE | 2016-01-06 | — | — | CN | claimed |
| US-12120945-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2024-10-15 | — | — | US | disclosed |
| US-20240239825-A1 | 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF | ZHEJIANG HUAXIAN PHOTOELECTRICITY TECHNOLOGY CO., LTD (CN) | 2024-07-18 | — | — | US | disclosed |
| US-20240239825-A1 | 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF | ZHEJIANG HUAXIAN PHOTOELECTRICITY TECHNOLOGY CO., LTD (CN) | 2024-07-18 | — | — | US | disclosed |
| CN-118201921-A | Lactams as CBL-B inhibitors selective for C-CBL | 基因泰克公司 | 2024-06-14 | — | — | CN | disclosed |
| US-11925104-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-03-05 | — | — | US | disclosed |
| CN-117279468-A | Phosphorescent excimer with preferred molecular orientation as monochromatic emitter for display and illumination applications | 李健 | 2023-12-22 | — | — | CN | disclosed |
| CN-109280063-B | Organometallic compound and organic light emitting device including the same | 三星显示有限公司 | 2023-12-12 | — | — | CN | disclosed |
| CN-111527615-B | Phosphorescent excimer with preferred molecular orientation as monochromatic emitter for display and illumination applications | 李健 | 2023-10-17 | — | — | CN | disclosed |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | UNITED STATES DEPARTMENT OF ENERGY | 2023-08-03 | — | — | US | disclosed |
| US-20100036118-A1 | Fused Ring Heterocycle Kinase Modulators | SGX PHARMACEUTICALS, INC. | 2010-02-11 | — | — | US | disclosed |
| EP-2134179-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX Pharmaceuticals, Inc. (US) | 2009-12-23 | — | — | EP | disclosed |
| US-7626021-B2 | Fused ring heterocycle kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-7626021-B2 | Fused ring heterocycle kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| US-7626021-B2 | Fused ring heterocycle kinase modulators | SGX PHARMACEUTICALS, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| WO-2008124850-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | US | disclosed |
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | SGX PHARMACEUTICALS, INC. (US) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287711-A1 | FUSED RING HETEROCYCLE KINASE MODULATORS | MAP3K20, TTK, MAP3K19 | NMT1 2599/4885ALDH1A1 4383/4885MAPT 3150/4885 |
| US-20100036118-A1 | Fused Ring Heterocycle Kinase Modulators | MAP3K20, TTK, MAP3K19 | NMT1 2599/4885ALDH1A1 4383/4885MAPT 3150/4885 |
| US-20240239825-A1 | 1,8-SUBSTITUTED CARBAZOLE-BASED PLATINUM COMPLEXES WITH HIGH RADIATION RATE AND APPLICATION THEREOF | LIG3, VIM, TRIM33 | NMT1 492/4885ALDH1A1 3843/4885MAPT 786/4885 |
| US-11925104-B2 | Organometallic compound and organic light-emitting device including the same | LEF1, GPX1, ODC1 | NMT1 1196/4885ALDH1A1 6/4885MAPT 1570/4885 |
| US-12120945-B2 | Display and lighting devices comprising phosphorescent excimers with preferred molecular orientation as monochromatic emitters | PDCD1LG2, EML4, EMC3 | NMT1 1193/4885ALDH1A1 2482/4885MAPT 489/4885 |
| US-20230247897-A1 | Phosphorescent Excimers with Preferred Molecular Orientation as Monochromatic Emitters for Display And Lighting Applications | PDCD1LG2, DCX, EMC2 | NMT1 1048/4885ALDH1A1 2808/4885MAPT 623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.